Anti-Chromogranin A / CHGA Antibody (CGA/413 + CHGA/777 + CHGA/798)

Anti-Chromogranin A / CHGA Antibody (CGA/413 + CHGA/777 + CHGA/798)is available at Gentaur for Next week Delivery.

Description: Chromogranin A is present in neuroendocrine cells throughout the body, including the neuroendocrine cells of the large and small intestine, adrenal medulla and pancreatic islets. It is an excellent marker for carcinoid tumors, pheochromocytomas, paragangliomas, and other neuroendocrine tumors. Co-expression of chromogranin A and neuron specific enolase (NSE) is common in neuroendocrine neoplasms. Reportedly, co-expression of certain keratins and chromogranin indicates neuroendocrine lineage. The presence of strong anti-chromogranin staining and absence of anti-keratin staining should raise the possibility of paraganglioma. The co-expression of chromogranin and NSE is typical of neuroendocrine neoplasms. Most pituitary adenomas and prolactinomas readily express chromogranin.

Immunogen Sequence:/

Target Alternative Name:Beta-Granin; CGA; CHGA; Chromogranin A Parathyroid Secretory Protein 1; ER-37; Pancreastatin; Parastatin; Parathyroid Secretory Protein 1; Pituitary Secretory Protein I; SP-I; Vasostatin I or II

Species Reactivities:Human, Monkey, Pig, Mouse and Rat

Tag Line:Monoclonal Antibody to detect Chromogranin A/CHGA in human samples

Formulation:Supplied in 10 mM PBS with 0.05% BSA & 0.05% azide

Purification: Protein A/G purified

Application:FC, IF, IHC

Positive Control:IHC: (A) Pheochromocytoma, (B) Pancreas, (C) Parathyroid, (D) Adrenal Gland

Application And Usages:FC: 0.5-1 µg/1X106 cells in 0.1 ml, IF: 0.5-1 µg/ml, IHC: 0.25-0.5 µg/ml for 30 minutes at RT

Handling:The antibody solution should be gently mixed before use